Company Focus

Gilead Sciences

Latest Gilead Sciences News

Gilead invests in Assembly Bio to advance clinical programs
Pharmaceutical
US biotech Assembly Biosciences has announced an equity investment of $20.1 million by Gilead Sciences to purchase additional common stock in the company and an amendment to their collaboration to advance the research and development of novel antiviral therapies with $10 million in accelerated funding.   20 December 2024


Latest News & Features of interest to Gilead Sciences

Latest In Brief for Gilead Sciences

Biotechnology
Colorado, USA-based OncoVerity announced the closing of a series A extension led by existing investors, argenX and RefinedScience. The value was not disclosed, but this extension follows a $30 million Series A fundraiser in March 2023.   22 November 2024

Latest Relevant Ones To Watch News


More in M&A >


Relevant Ones to Watch Companies

Reset all filters
Refine Search